New Targeted Therapy for Brain Tumors is Now Offered at UnityPoint Health - John Stoddard Cancer Center
January 23, 2025
January 23, 2025
WEST DES MOINES, Iowa, Jan. 23 -- UnityPoint Health issued the following news release:
UnityPoint Health - John Stoddard Cancer Center has become the first in Iowa to treat a patient with GammaTile Therapy, an innovative approach to combating brain tumors. This FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) is designed to delay tumor regrowth while preserving healthy brain tissue, offering new hope to patients facing aggressive brain tumors.
"GammaTile . . .
UnityPoint Health - John Stoddard Cancer Center has become the first in Iowa to treat a patient with GammaTile Therapy, an innovative approach to combating brain tumors. This FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) is designed to delay tumor regrowth while preserving healthy brain tissue, offering new hope to patients facing aggressive brain tumors.
"GammaTile . . .